Experiments are presented to show the effects of (1) propranolol on tbe response of systolic blood pressure and diastolic blood pressure to bilateral carotid artery occlusion in choralose-anesthetized dogs; (2) the effects of propranolol on acute hypertensive states in chloralose-anesthetized dogs; and (3) the effects of propranolol on the response of trained awake dogs to bilateral carotid artery occlusion. Acutely, propranolol in successive doses administered intravenously lowered the systolic and diastolic blood pressure response to 35% and 27%, respectively, of the original response during bilateral carotid artery occlusion. There was no significant change in the systolic and diastolic blood pressure of controls. Systolic blood pressure, diastolic blood pressure, ventricular contractile force, dp/ dt, and heart rate, which were elevated by double vagotomy and carotid sinus denervation, were returned to control levels by doses of propranolol. Hypertensive blood pressures of dogs infused with angiotensin and norepinephrine were made normotensive by simultaneous infusion or bolus injection of propranolol. Administered centrally in "isolated head" experiments (dogs) and ventromedial nucleus (in cats), propranolol had no effect on acute hypertension or on carotid sinus reflex response or ventromedial nucleus stimulation. The systolic and diastolic blood pressure responses to bilateral carotid artery occlusion in awake dogs were not significantly altered after the 1st week of daily treatment with propranolol (2.5 mg/kg). The responses of both the systolic and diastolic blood pressure to bilateral carotid artery occlusion decreased, however, after 1 week of daily propranolol administration at 5.0 mg/kg and there was a further decrease in heart rate, and in systolic and diastolic blood pressure responses to bilateral carotid artery occlusion when propranolol was raised to 7.5 mg/kg in daily doses for 1 week.
FROHLICH 1 focused attention on the use of ^-blocking agents against hypertension. The mechanism by which /3blocking agents modify elevated blood pressure seems to be unclear. In our preliminary experiments, we found that in anesthetized dogs propranolol decreases the response of both systolic and diastolic blood pressure to common carotid occlusion. 2 Extension of our work later demonstrated that in acute hypertension, produced by bilateral vagotomy and carotid sinus denervation, blood pressure was returned to normotensive levels by successive doses of propranolol. 3 Hyde et al. 4 subsequently showed in instrumented dogs that concomitant with the decrease in systolic and diastolic blood pressure and heart rate in acutely hypertensive dogs the end-diastolic volume and the enddiastolic pressure increased, while the cardiac output decreased and maximum ejection time was lengthened. It seemed apparent that a diminution in cardiac function might be the mechanism by which propranolol acted to reduce blood pressure. Two other mechanisms, however, have attracted our attention and merit consideration: (1) Buhler et al. 5 proposed that propranolol acts as an antirenin substance to lower blood pressure in patients who have moderate to high renin secretion with their hypertension. They point to the ineffectiveness of propranolol in patients in whom the renin secretion is low and in whom, indeed, it may be contraindicated. (2) Garvey and Ram (i> 7 very recently presented data which they believe show that propranolol acts at the hippocampus to reduce sympathetic activity and thereby to promote peripheral vasodilation and lower blood pressure. We present our recent results in an attempt to shed further light on a problem that needs clarification, if a fuller understanding of the mechanism of action of propranolol in hypertension is to be had. The problem is by no means solved; we have attempted to contribute to a better understanding by using a variety of laboratory approaches with which we are familiar.
Methods

EXPERIMENTS ON ANESTHETIZED DOGS
Bilateral Carotid Artery Occlusion
Mongrel dogs of either sex weighing 18-22 kg were pretreated with morphine, 2 mg/kg, subcutaneously (sc). The dogs were given chloralose, 80 mg/kg, intravenously (iv) 15 minutes later. A tracheotomy was performed; the carotid sheaths were opened, the vagi were loosely ligated, and the carotid sinuses were completely exposed. Loose ligatures were placed around the carotid sinus nerves. The femoral artery on one side and the femoral vein on the opposite side were exposed for cannulation. Blood pressure was monitored by a Sanborn or a Honeywell 5600 VOL. 41, No. 2, August 1977 recorder using a Statham transducer (P230c) connected to the artery via polyethylene tubing. An electrocardiogram (ECG) (lead II) was recorded. For many experiments in this group data were collected by a Honeywell magnetic tape recorder connected to an on-line catheterization computer.
Left ventricular pressure and dp/dt were recorded from open-chest preparations. A Honeywell Accudata 132 differentiator was used for dp/dt recording. A small stab wound was made in the apex of the left ventricle and a hard polyethylene catheter, connected to a Statham transducer, was quickly inserted. The heart was cradled in such a way that the Statham transducer was approximately 6 cm above it. The vagus nerves were sectioned and, after stabilization of the blood pressure, the carotid arteries were occluded for 15-30 seconds. Two to three control responses of blood pressure and the aforementioned parameters were recorded before administration of propranolol. Occlusions were performed at 5-minute intervals beginning just before injection of the drugs, and again 5 minutes after drug administration and just prior to the next dose. Doses of propranolol (0.2 rug/kg) were administered 10 minutes apart via the femoral vein through an indwelling polyethylene catheter-syringe connection. The experiment was concluded after insignificant changes in hemodynamics were observed on occlusion of the common carotid arteries. Experiments were performed on control dogs in the manner described above, except that no propranolol was administered.
Acute Hypertension
Dogs were prepared in the manner described above with the exception that, after bilateral vagotomy, the carotid arteries were occluded for 30 seconds to assess the carotid sinus reflex response. The carotid sinus nerves, which had been loosely ligated, were tied in order to denervate the sinuses. The carotid arteries were again occluded after stabilization of blood pressure to be certain that no neural elements remained functional. Propranolol was then administered after 10 minutes via the femoral vein in doses of 0.2 mg/kg at intervals of 10 minutes. Anesthetized control dogs, whose vagi had been sectioned and carotid sinuses denervated, received no propranolol.
The Effects of Propranolol against Angiotension and Norepineph rine
These experiments were designed to widen our observations regarding the action of propranolol against hypertensive states produced by mechanisms other than carotid sinus denervation and bilateral vagotomy or by bilateral carotid artery occlusion with the vagi sectioned. Angiotensin II and norepinephrine were infused in separate experiments via the femoral vein as described below.
Angiotensin. Dogs of either sex weighing 16-22 kg were anesthetized with pentobarbital sodium (30 mg/kg, iv). Blood pressure, heart rate, left ventricular pressure, dp/ dt, and ECG were recorded as described for acute experiments. Renal artery blood flow was monitored by a Statham electromagnetic pulsed square wave flowmeter, model SP22O2. The vagi were left intact.
Angiotensin II (Hypertensin, Ciba-Geigy), made freshly for each experiment from powder and prepared in aqueous solution, was infused at the rate of 0.4 /tg/kg per min, using a Sigma infusion pump to produce sustained and stable hypertension. Ten minutes after the angiotensin infusion was begun, infusion of propranolol (0.1 mg/kg per min) was started. From this time both drugs were infused simultaneously until the blood pressure, elevated by angiotensin infusion, had returned to or below control levels. Control untreated dogs were infused with angiotensin II only for 30 minutes.
Norepinephrine. The preparations and the monitoring techniques were the same as for the angiotensin experiments, except that dp/dt and blood flow were not measured. Norepinephrine (solutions were made fresh for each experiment from powder dissolved in distilled water) was infused for 30 minutes via the femoral vein, using a Sigma infusion pump, at a rate of 1.5 Mg/kg per min to produce sustained and stable hypertension. Doses of propranolol (0.2 mg/kg) were administered at 10-minute intervals after stabilization of the elevated blood pressure and during the constant norepinephrine infusion. The experiment was concluded when all hemodynamic parameters had returned to or had fallen below values for prenorepinephrine infusion. Control dogs were infused with same dose of norepinephrine as the propranolol-treated dogs, but no propranolol was administered to them.
Effects of Centra! Administration of Propranolol on the Carotid Sinus Reflex Response and on the Pressor Response to Electrical Stimulation of the Ventromedial Hypothalamic Nucleus
Cats of either sex, weighing 2.5-4 kg, were anesthetized with chloralose (80 mg/kg); a tracheotomy was performed and the vagi were sectioned. Blood pressure was recorded from the femoral artery through a Statham transducer connected by polyethylene tubing to a Physiograph recorder. The skull was trephined, and a cannula-electrode, which was a 22-gauge needle insulated (to the tip), was passed into the ventromedial nucleus of the hypothalamus by the stereotaxic procedure of Jasper and Ajomone-Marsan. 8 Electrical stimulation through the needle-electrode resulted in a prominent pressor response. The stereotaxic coordinates for the ventromedial nucleus were: anterior, 12 mm; lateral, 1-1.5 mm; and vertical, 5 mm.
Studies on the Isolated Head
The experimental procedure of Heymans 9 was used. The dog whose head was functionally isolated from its trunk, designated as the "receiver" dog, was pretreated with morphine (2 mg/kg, sc) and anesthetized 15 minutes later with chloralose (80 mg/kg, iv). A low tracheotomy was performed. Blood pressure was monitored via the femoral artery with a Statham transducer. The carotid arteries and external jugular veins were dissected free along their entire length. The carotid sinus nerves were loosely ligated. The veterbral arteries and veins at the base of the neck were loosely ligated. Muscle and connective tissue on the ventral side of the neck at C 2 were carefully dissected in preparation for inserting the Semaan-Hey-mans instrument from the ventral side to the dorsal side of the neck. This is a U-shaped, stainless steel instrument, which is fitted with a smaller U-shaped structure that is used to surround the spinal cord. The dog was rotated on its ventral side and the head was supported from same side. The skin and muscle on the dorsal area of the skull and neck were dissected, down below the level of C 2 . The spinovertebral arteries on either side were isolated and ligated; and a laminectomy was performed at C 2 to expose the spinal cord. The dog was transfused with whole blood throughout this procedure. The spinal cord was exposed and, after opening the dura mater, it was manipulated, by using a rubber dental dam, in such a way that the anterior spinal artery was made accessible for placement of a loose ligature around it. The steel Semaan-Heymans instrument was brought from the ventral side of the neck to the dorsal side at Q . The small U-shaped structure inside the Semaan-Heymans clamp was carefully manipulated to fit it around the spinal cord and a crossbar was arranged between the posts of the larger U-shaped instrument in such a way that screws could be adjusted to mildly compress the spinal sinuses on either side of the cord without compressing the cord itself. The carotid sinus nerves were loosely ligated in preparation for subsequent tying.
A second dog, the "donor" dog, was anesthetized with morphine-chloralose (2 mg/kg, sc, and 80 mg/kg, iv, respectively). The carotid arteries and the external jugular veins were freed along their entire length. The vagi were left intact. The carotid arteries and the jugular veins were anastomosed to the carotid arteries and jugular veins of the receiver dog. Blood pressure was monitored through the femoral artery. A dose of norepinephrine (2.5 /ng/kg) was administered via the femoral vein to the donor dog. An increase in blood pressure in the donor dog and a simultaneous reflex decrease in pressure in the receiver dog was thought to show the completeness of the preparation (no leakage between the trunk and the head of the receiver dog). The carotid sinuses were denervated and the vagi sectioned in the head of the receiver dog. After stabilization of the elevated blood pressure, propranolol was administered via carotid arteries to the head of the receiver dog in doses of 0.05, 0.075, and 0.1 mg/kg at intervals of 10 minutes.
EXPERIMENTS ON AWAKE DOGS
Carotid arteries and vagus nerves of dogs used for these experiments were surgically exteriorized in loops of skin under anesthesia. Training of the dogs for studies of blood pressure and heart rate was begun 2-3 weeks after surgery. The dogs were placed on a padded table, while a 20guage needle, connected by polyethylene tubing to a Sanborn or Statham transducer number P2330C, was introduced into the femoral artery. The area of the femoral triangle previously had been anesthetized with 1% procaine.
One milliliter of a 1% procaine solution was introduced into the lumen of the carotid loops to block the aortic depressor nerves prior to carotid artery occlusion. An increase in heart rate after injection of procaine was taken to indicate vagal anesthesia. Control tests to determine the blood pressure response to carotid occlusion were performed on each dog for a period of 3-4 weeks. The dogs were started on daily doses of propranolol when control blood pressure responses to occlusion of the common carotid arteries varied insignificantly. Propranolol was administered daily to each dog orally in doses of 2.5 mg/kg for 1 week, followed in successive weeks by daily doses of 5.0 mg/kg and 7.5 mg/kg. The daily administration was designed to simulate clinical practice. The doses were increased to assess a possible dose-dependent effect. Blood pressure responses to bilateral carotid artery occlusion were observed twice each week under the same conditions described for the control period. At least three blood pressure and heart rate responses were observed at each of the weekly test periods.
Data for all experiments and experimental designs were analyzed for statistical significance with Student's f-test and the Honeywell catheterization computer. Figure 1 shows a decrease in the mean response of both systolic and diastolic blood pressure to bilateral common carotid artery occlusion after repeated iv doses of propranolol. The decrement in response was dose-dependent after the first dose. After the second dose, 10 minutes after the first dose, the mean systolic blood pressure response to carotid occlusion fell to 70%, and the mean diastolic blood pressure response fell to 66%, of the control. The third dose caused the response of systolic blood pressure to decrease immediately to 35% of the control response and the diastolic pressure decreased to 27% of the control response. Five minutes after the last dose, the responses of systolic and diastolic blood pressure fell 87% and 90%, respectively. Although other parameters are not shown in Figure 1 , the heart rate, the peak left ventricular pressure, and the peak dp/dt decreased at a rate corresponding to the decrease in blood pressure. The mean systolic and diastolic blood pressure before occlusion were 145 ± 6.0 (SE) mm Hg and 95 ± 5.0 mm Hg, respectively. Very little (0.5 mm Hg) change in systolic or diastolic blood pressure occurred after the first dose of propranolol. The second and third doses of propranolol, however, caused decreases of 10-15 mm Hg in systolic blood pressure and 5-10 mm Hg in diastolic pressure immediately after iv injection. After 5 minutes, at the time the reflex was tested, however, the blood pressure had returned to levels that were insignificantly different from the controls. The decrease in response to carotid occlusion that was observed, therefore, did not result from the hypotensive effect of propranolol. At the end of the experimental period (25 minutes), the mean systolic blood pressure was 125 ± 8.0 (SE) mm Hg and the mean diastolic pressure was 82 ± 7.0 mm Hg, but there was less than 15% of the initial response of systolic blood pressure and only 10% of the response of diastolic blood pressure to carotid occlusion. Table 1 presents the effects of propranolol on the mean systolic and diastolic blood pressure, the mean peak left ventricular contractile force, the mean peak dp/dt, and the mean heart rate changes following double vagotomy and carotid sinus denervation. The mean systolic blood pressure fell from 250 mm Hg to 148 mm Hg after successive doses of propranolol. The mean systolic blood pressure in the untreated dogs fell only from 240 mm Hg to 220 mm Hg. The mean diastolic blood pressure in the dogs receiving propranolol diminished from 180 mm Hg to 95 mm Hg after the last dose of propranolol. The mean diastolic blood pressure in the untreated dogs decreased from 170 mm Hg to 155 mm Hg by the end of the experimental period. The left ventricular pressures, which were 245 mm Hg and 255 mm Hg for control groups 1 (untreated) and 2 (treated), respectively, decreased after denervation to 160 mm Hg in the treated dogs after the last dose of propranolol, but fell only to 220 mm Hg in the untreated dogs. The mean value for dp/dt decreased after propranolol administration from 2,000 to 1,000 mm Hg/sec; but in the untreated group dp/dt fell from 2,200 after denervation to 1,990 by the end of the experimental period. Heart rate decreased in the treated group to 90 beats/min and 200 beats/min in the untreated group. Table 2 shows the systolic and diastolic arterial blood pressure response, the peak left ventricular contractile force, peak dp/dt, heart rate, and renal arterial blood flow during infusion of angiotensin alone followed by simultaneous infusion of angiotensin and propranolol. The mean systolic blood pressure rose from 148 mm Hg to 250 mm Hg during the 10-minute period of angiotensin infusion, but the mean systolic blood pressure in the dogs simultaneously infused with angiotensin and propranolol rose from 150 mm Hg to only 196 mm Hg. During the 10minute infusion of angiotensin alone the mean diastolic Results are expressed as mean ± SEM. Six control dogs (control 1) were untreated after denervation. Control 2 dogs were treated in stepwise doses at 10-minute intervals. The differences between the treated and untreated dogs were significant beginning with the dose of 0.1 mg/kg in each parameter (P < 0.050).
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* Not significant. ' t Significant (P < 0.05).
TABLE 2 Effect of Angiotensin II Infusion Alone and Simultaneously with Propranolol in Two Groups of Dogs over a 30-Minute Period
Angiotensin alone blood pressure rose from 110 mm Hg to 225 mm Hg, whereas in the dogs infused simultaneously with both drugs during the 10-minute period the diastolic pressure rose only from 100 mm Hg to 165 mm Hg. The mean left ventricular pressure in the group given only angiotensin rose from 155 to 245 mm Hg; but in the group receiving both drugs simultaneously the left ventricular pressure rose only from 155 to 200 mm Hg. The value of dp/dt in the angiotensin-infused group rose only from 1,100 to 1,400 mm Hg/sec. The heart rate did not change significantly, decreasing from 160 to 154 beats/min in the 10minute period of infusion. In the group receiving both drugs heart rate fell from 165 to 130 beats/min. The renal blood flow decreased from 150 to 40 ml/min in the angiotensin group during the 10-minute period of infusion. This change was not significantly different in the group receiving both drugs simultaneously. At the 30-minute period during infusion of angiotensin the systolic blood pressure was 243 mm Hg, compared to 161 mm Hg in the propranolol-plus angiotensin-infused group. The diastolic blood pressure in the angiotensin-infused group was 220 mm Hg, but in the propranolol-plus angiotensin-infused group it was 94 mm Hg. Left ventricular pressure after 30 minutes of angiotensin infusion was 247 mm Hg and dp/dt was 1,760 mm Hg/sec. Left ventricular pressure in the angiotensin-propranolol group after 30 minutes of infusion was 165 mm Hg, and dp/dt was 900 mm Hg/sec. Heart rate in the angiotensin-infused group was 154 beats/ min, but heart rate in the propranolol-angiotensin group was 90 beats/min. Renal blood flow was sharply reduced in the angiotensin group from 137 to 37 ml/min in the 30minute period. There was no significant difference from values for the angiotensin group in renal blood flow in dogs in which both drugs were infused simultaneously during the 30-minute period. In the former it fell from 135 to 51 ml/min.
All of the hemodynamic parameters described above, except renal blood flow, showed the influence of propranolohon the response to angiotensin. Systolic and diastolic arterial blood pressure, ventricular contractile force, dp/ dt, and heart rate all were reduced significantly while angiotensin was infused with propranolol. We regard these changes as significant. Table 3 shows the effects of propranolol on the hemodynamic parameters in dogs infused continuously with norepinephrine. Values for mean systolic blood pressure, diastolic blood pressure, and mean heart rate were not significantly different for control group 1 and control group 2 dogs. These values changed during 10 minutes of continuous infusion of norepinephrine as follows: The mean arterial systolic blood pressure of control groups 1 and 2 rose to 240 and 245 mm Hg, respectively. The mean arterial diastolic blood pressure in control group 1 rose to 153 mm Hg and to 160 mm Hg in control group 2. The mean heart rate decreased to 101 beats/min in control group 1 and 104 in control group 2. All of these values decreased after successive doses of propranolol in the control group 2 dogs. The mean systolic arterial blood pressure decreased from 160 mm Hg to 90 mm Hg. Peak left ventricular pressure was decreased from 247 mm Hg to 122 mm Hg. The heart rate, which had already decreased reflexly because of the norepinephrine infusion, fell to 75 beats/min. There were no significant changes in blood pressure, contractile force, or heart rate (except reflexly) in control group 1 dogs (not treated with propranolol) during the course of the norepinephrine infusion). The above results are indeed significant and indicate the effectiveness of propranolol in lowering blood pressure that has been increased by norepinephrine. Table 4 presents the results of studies on the isolated head in which acute hypertension was produced in the receiver dog by bilateral vagotomy and carotid sinus denervation. A test dose of norepinephrine, 2.5 /u-g/kg, was injected into the femoral vein of the donor dog before denervation to demonstrate the elevation of blood pressure in the donor dog and the reflex fall in blood pressure in the receiver dog. This demonstrated that there was no "leakage" of blood from the head of the receiver dog to its 
Studies on the Isolated Head
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Control dogs (control 1) were infused with norepinephrine (1.5 ftg/kg per min) and were not treated with propranolol. A second group of dogs (control 2) were infused with the same dose of norepinephrine but were treated at 10-minute intervals with propranolol (0.2 mg/kg) iv. Each parameter of the propranolol-treated group was significant (P < 0.05) at the second dose of propranolol. There were four animals in each group. Results are presented as the mean ± SEM.
" Not significant. t Significant (P < 0.05).
trunk. On the other hand, when norepinephrine was administered to the donor dog after denervation of the carotid sinuses of the receiver dogs there was an elevation of blood pressure only in the donor dog and no change in the receiver dog. Table 5 shows the responses of blood pressure in chloralose-anesthetized cats after electrical stimulation of the ventromedial nucleus and after alternate occlusion of the common carotid arteries. It may be observed that propranolol, administered directly into the hypothalamus, did not change the response of the blood pressure after ventromedial nucleus stimulation or alternate bilateral carotid artery occlusion. Table 6 presents changes in blood pressure and heart rate after carotid artery occlusion both during control periods and during daily treatment with increasing doses of propranolol over a 3-week period. It may be seen that the blood pressure and the heart rate responses to bilateral carotid artery occlusion were not appreciably affected during the 1st week of daily administration of propranolol (2.5 mg/kg). The effect of propranol.ol during the succeeding 2 weeks, as the doses were increased, was evident from both blood pressure and heart rate response to bilateral carotid artery occlusion. Systolic blood pressure responses decreased by 16% and diastolic pressure decreased by 19% from the control values. Systolic blood pressure responses decreased by 42% and diastolic blood pressure by Propranolol was given in stepwise doses via the anastomosed carotid arteries to the head of the recipient dog at 10minute intervals. The blood pressure of the recipient dog was elevated by carotid sinus denervation and double vagotomy. See text for explanation of preparation. Note no change in blood pressure in the recipient dog, but a significant decrease in blood pressure (P < 0.05) in the donor dog. There were three dogs in these experiments. Results are presented as mean ± SEM. * Significant (P < 0.05). t Not significant. 82% during administration of daily doses (7.5 mg/kg) of propranolol. Heart rate response to carotid occlusion during daily doses of 2.5 mg/kg was essentially the same as the control. The increase in the heart rate during carotid occlusion after daily doses of 5.0 mg/kg or propranolol, however, diminished by'33%. After daily doses of 7.5 mg/ kg or propranolol the heart rate increase from carotid occlusion diminished to 7.6% of the control response.
EXPERIMENTS ON ANESTHETIZED CATS
EXPERIMENTS ON AWAKE DOGS
Discussion
The foregoing resul.ts show that propranolol lowers the systolic and diastolic arterial blood pressure in anesthetized, acutely hypertensive dogs and lowers the responses of these pressures to bilateral carotid artery occlusion in both anesthetized and awake dogs. It appears to us that the effect of propranolol on the heart is the essential avenue through which the drug lowers arterial blood pressure in the hypertensive animal and decreases the responses of blood pressure in elicitation of the carotid sinus reflex. Heart rate, peak left ventricular pressure, and peak dp/dt in the acute experiments seem to support this view. In 1972 we compared propranolol to other /3-adrenergic blocking agents with respect to their effects on the blood pressure response to bilateral carotid artery occlusion and on the acutely hypertensive arterial blood pressure in anesthetized dogs. Practolol, sotalol, and pindolol were found to be much less effective in lowering blood pressure and they were equally less effective in decreasing heart rate, peak left ventricular pressure, and peak dp/dt. 3 The results of experiments with angiotensin infusion agree significantly with the experiments on the other models. There was, of course, no antagonism of angiotensin by propranolol at the receptor sites of the arteriolar bed, where angiotensin has its major action. The blood flow data indicate that the vasoconstriction caused by angiotensin was present during the simultaneous infusion of angiotensin and propranolol. In spite of this, however, the arterial blood pressure decreased significantly and was brought approximately to the control levels after 30 minutes of simultaneous infusion of angiotensin and propranolol. The norepinephrine infusion experiments were slightly different in design. Nevertheless, the effects of propranolol against the hypertension caused by norepinephrine were not different from effects against angiotensin. One point which may tend to make clearer the interpretation of these experiments should be mentioned. The norepinephrine effect on the heart, a /3-adrenergic effect, was blocked by propranolol. Hence the heart rate (although reflexly slowed to some extent) and the contractile force effect of norepinephrine are directly antagonized by propranolol. It should not be expected that propranolol would effect the action of norepinephrine on peripheral blood vessels, because norepinephrine acts at these sites on a-adrenergic receptors. This means, therefore, that in both the angiotensin and norepinephrine infusion experiments, we are dealing principally with cardiac effects of propranolol against the hypertension caused by both of the 4 referred to above, support this view. Hypertensive blood pressure in these experiments was returned to normal levels by propranolol as heart rate was slowed, ventricular contractile force was reduced, dp/dt was diminished, and cardiac output was lowered. Also in these experiments end-diastolic pressure was increased and maximum ejection time and cycle length were increased. These observations would explain the effect of propranolol on diastolic as well as systolic blood pressure, because the combination of the above factors results in decreased "runoff time" and results in a fall in diastolic pressure.
Our experiments should not be taken to mean that in clinical hypertension propranolol does not act to antagonize renin secretion in the presence of moderate to high renin secretory activity, as a means of lowering blood pressure. There is reason to believe from our experiments, however, that other mechanisms may be involved. It is inconceivable that, in the angiotensin and norepinephrine experiments we have reported here, propranolol would act to lower the arterial systolic and diastolic blood pressure by blocking renin secretion, because in both cases renin secretion would be expected to be decreased. The infused angiotensin would block renin secretion by the negative feedback mechanism, and the elevation of the blood pressure by norepinephrine would block renin secretion.
The failure of propranolol to affect the hypertension in anesthetized cats following ventromedial nucleus stimulation makes it less likely, in our view, that propranolol may have central action at this site. The isolated head experiments, in which the receiver dog was made hypertensive, would also discount a central action of propranolol, because the blood pressure in the receiver dog of such experiments is not lowered by propranolol administered via the carotid arteries directly to the isolated head.
The experiments of Garvey and Ram 6 nevertheless merit considerable attention. These authors believe they have demonstrated that propranolol administered to rats accumulates in the hippocampus either as the unmetabolized substance or as its metabolites. They believe that this is a primary basis for the postulation that propranolol acts at the hippocampus to decrease sympathetic activity. They have shown, additionally, that there is a decrease in sympathetic nerve volleys and in blood pressure in animals treated acutely with propranolol. This is indeed an attractive postulation which broadens further the possible mechanisms of action of propranolol. It is important to keep in mind, however, that accumulation of a drug or its metabolites at a given site is not prima facie evidence that the drug may have its major action at that site. Seigel and Tassoni 10 however, have recently described the hippocampus as having central sympathetic efferent fibers to the hypothala-mus. This, if substantiated functionally, would give support to the postulation of Garvey and Ram. 6 In spite of this we find it difficult for our angiotensin experiments to explain why the vasoconstriction caused by angiotensin is not reversed on infusion of propranolol if propranolol were acting centrally to decrease sympathetic activity. It is also of great interest in these experiments that heart rate, contractile force and dp/dt are returned to or below control levels by propranolol infusion, although blood flow is essentially unaffected. It is important to mention at this point the work of Kawashiama et al.," who showed, using radioimmunoassay technique, that /-propranolol accumulates rapidly in the heart as it concomitantly decreases in plasma concentration. The d form of propranolol, on the other hand, is metabolized rapidly in the blood. These results keep open the question of whether the accumulation of propranolol at a given site may be of any significance in relation to its action. It is reasonable to assume, however, that accumulation of /propranolol in the heart may have greater significance regarding its cardiac effects than the accumulation in the hippocampus. We believe this view would be more in line with our opinion that propranolol may have its major effect on the heart rather than at some site in the central nervous system.
